Report - ANEXO I RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTOec.europa.eu/health/documents/community-register/2007/... · Foram relatados casos de fibrose sistémica nefrogénica (FSN) associada

Please pass captcha verification before submit form